Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Angiography for Neuroma Perfusion
NCT06164392Phase 4Withdrawn
- Sponsor
- Northwestern University
- Start
- Dec 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in Neuroma, sponsored by Northwestern University. Planned start Dec 2024; status: withdrawn.
02
Drugs
indocyanine green
03
Conditions
Neuroma
Beyond the preview
Go deeper on NCT06164392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06164392.